Literature DB >> 26152440

Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.

Jun Li1, Zahava Berkowitz2, Ingrid J Hall2.   

Abstract

PURPOSE: To assess changes of prostate-specific antigen (PSA) testing following recent US Preventive Services Task Force (USPSTF) prostate cancer screening recommendations using 2005 to 2013 National Health Interview Survey data.
METHODS: We calculated the percentage of PSA testing among men ≥40 years by age group and age-adjusted race for each survey year. Differences between years were assessed with linear contrasts after combining all years' data.
RESULTS: The overall percentage of PSA testing was highest in 2008 and decreased significantly in 2013. Compared with 2008, each age group had significantly lower screening percentages in 2013, especially men ≥75 years old (-14.0% points; P < .001). Both men aged 50 to 74 and men aged ≥75 had significantly lower percentages in 2013 than in 2010. For white and black men, the PSA testing percentages were highest in 2008 and decreased significantly in 2013. Only white men had a significantly lower percentage in 2013 than in 2010.
CONCLUSIONS: Significant declines in PSA testing from 2008 to 2013 in men ≥75 years old may reflect the impact of the 2008 USPSTF recommendations. While the cause of the decreases in PSA testing between 2010 and 2013 among men aged 50 to 74 years old and white men is unknown, the decreases may suggest the early effects of the 2012 recommendations. © Copyright 2015 by the American Board of Family Medicine.

Entities:  

Keywords:  Cancer Screening; Prostate Cancer; Prostate-Specific Antigen

Mesh:

Substances:

Year:  2015        PMID: 26152440      PMCID: PMC6077843          DOI: 10.3122/jabfm.2015.04.150062

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

2.  Shared decision making in prostate-specific antigen testing with men older than 70 years.

Authors:  Jun Li; Zahava Berkowitz; Thomas B Richards; Lisa C Richardson
Journal:  J Am Board Fam Med       Date:  2013 Jul-Aug       Impact factor: 2.657

3.  National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.

Authors:  Michael W Drazer; Sandip M Prasad; Dezheng Huo; Mara A Schonberg; William Dale; Russell Z Szmulewitz; Scott E Eggener
Journal:  Cancer       Date:  2014-02-12       Impact factor: 6.860

4.  Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.

Authors:  David H Howard; Florence K Tangka; Gery P Guy; Donatus U Ekwueme; Joseph Lipscomb
Journal:  Health Aff (Millwood)       Date:  2013-03       Impact factor: 6.301

5.  Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Authors:  Joshua A Cohn; Chihsiung E Wang; Justin C Lakeman; Jonathan C Silverstein; Charles B Brendler; Kristian R Novakovic; Michael S McGuire; Brian T Helfand
Journal:  Urol Oncol       Date:  2013-08-02       Impact factor: 3.498

  5 in total
  21 in total

Review 1.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

2.  Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men.

Authors:  Charles R Rogers; Michael J Rovito; Musse Hussein; Ogechi Jessica Obidike; Rebekah Pratt; Mark Alexander; Jerica M Berge; Marc Dall'Era; Jeffrey W Nix; Christopher Warlick
Journal:  Am J Prev Med       Date:  2018-11       Impact factor: 5.043

3.  Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.

Authors:  Jarrett A Johnson; Richard P Moser; Gary L Ellison; Damali N Martin
Journal:  J Community Health       Date:  2020-10-16

4.  Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?

Authors:  Izak Faiena; Stuart Holden; Mathew R Cooperberg; Stuart Holden; Howard R Soule; Jonathan W Simons; Todd M Morgan; David F Penson; Alicia K Morgans; Maha Hussain
Journal:  J Clin Oncol       Date:  2018-02-05       Impact factor: 44.544

5.  Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

Authors:  Jun Li; David A Siegel; Jessica B King
Journal:  Ann Epidemiol       Date:  2018-03-06       Impact factor: 3.797

6.  Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate.

Authors:  Daniel T Oberlin; David D Casalino; Frank H Miller; Richard S Matulewicz; Kent T Perry; Robert B Nadler; Shilajit Kundu; William J Catalona; Joshua J Meeks
Journal:  Urology       Date:  2016-03-07       Impact factor: 2.649

7.  Prostate-specific antigen screening: An update of physician beliefs and practices.

Authors:  Ingrid J Hall; Sun Hee Rim; Greta M Massetti; Cheryll C Thomas; Jun Li; Lisa C Richardson
Journal:  Prev Med       Date:  2017-08-06       Impact factor: 4.018

8.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

9.  Knowledge of and Attitudes Toward Evidence-Based Guidelines for and Against Clinical Preventive Services: Results from a National Survey.

Authors:  Paula M Lantz; W Douglas Evans; Holly Mead; Carmen Alvarez; Lisa Stewart
Journal:  Milbank Q       Date:  2016-03       Impact factor: 4.911

10.  Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005-2015.

Authors:  Zahava Berkowitz; Jun Li; Thomas B Richards; Pamela M Marcus
Journal:  Am J Prev Med       Date:  2017-10-16       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.